A Lesson from Enron Nicholas Wade's article, "Fraud Happens: What to Do About It,"1 touches on several aspects of the phenomenon of scientific fraud in the wake of Jan Henrik Schon's scandal at Bell Labs. However, I found myself a bit disappointed reading about actions and checkpoints that do not work in curbing fraud in science and not much in terms of "what to do about it." Although an attempt was made to shift the responsibility of fraud detection to the lab chief, in many cases the chie

I fully agree with T.V. Rajan's Commentary on funding.1 Regrettably, he is also right about being a hopeless 19th-century romantic. This is because he and many others like him, including me, do not possess the influence to change the trend that has afflicted science and its funding for the past two decades: commercialism. As in other domains where public funds are used, those in charge of these funds believe that their foremost responsibility is to show a fast and hefty return on their investm